Search Articles
TRENTON, N.J. – Pfizer, Warner-Lambert, and Ranbaxy conspired to delay introduction of generic Lipitor to reap hundreds of millions of dollars in extra profits, Walgreen and others claim in a federal antitrust complaint. For more securities news, click here to check out Courthouse News’ Securities Law Review.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.